Suthipol Udompunturak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Suthipol Udompunturak has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Ahthit Yindeengam
Mahidol University
1 shared publication - Irene Ruengkhachorn
Gynecologic Oncology Division, Department of Obstetrics & Gynecology, Faculty of Medicine Siriraj Hospital Mahidol University Bangkok Thailand
1 shared publication - Nida Jareemit
Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital Mahidol University Bangkok Thailand
1 shared publication - Pairash Saiviroonporn
Division of Diagnostic Radiology, Department of Radiology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
1 shared publication Prajak Thanapiboonpol
Mahidol University
1 shared publication- Rattiya Phianpiset
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand
1 shared publication
Latest Publications
- 7 March 2022
- Published by Wiley in Asia-Pacific Journal of Clinical Oncology
- Vol. 18 (5) , E495-E506
Predictive factors associated with resistance to initial methotrexate treatment in women with low‐risk gestational trophoblastic neoplasia
Aim: To compare clinical characteristics and identify factors predictive of resistance to initial treatment with methotrexate‐folinic acid (MTX‐FA) in women with low‐risk gestational trophoblastic neoplasia (GTN).Methods: Retrospective chart reviews were conducted in patients diagnosed with low‐risk GTN who were treated with MTX‐FA at Siriraj Hospital between 2002 and 2018. Demographic data, disease characteristics, treatment response, toxicity, and data of the subsequent pregnancy were collected and analyzed. Groups of patients who were responsive or resistant to treatment were compared. Stepwise logistic regression analysis was used to identify factors predictive of resistance to methotrexate chemotherapy.Results: Totally, 113 patients were eligible for analysis. The primary remission rate was 55.8% with first‐line MTX‐FA. All other patients achieved remission by subsequent treatment with actinomycin D or multiple‐agent chemotherapy. Relapse of disease occurred in 4.4% and the overall survival rate was 99.1%. Univariate analysis showed that pretreatment serum hCG, neutrophil‐to‐lymphocyte ratio at baseline, and serum hCG ratio of the first three consecutive cycles (C) were significantly associated with resistance to MTX‐FA. Independent factors that predict failure to respond to first‐line MTX‐FA were pretreatment serum hCG ≥15,000 IU/L, a less than 4.8‐fold reduction of serum hCG between cycle 1 and cycle 2 (C1/C2), and a less than seven‐fold reduction of serum hCG from cycle 2 to cycle 3 (C2/C3).Conclusions: First‐line MTX‐FA treatment is effective in 55.8% of patients. Pretreatment serum hCG, and serum hCG ratio between consecutive treatment cycles can predict initial treatment failure.
- 7 March 2022
- Published by Wiley in Asia-Pacific Journal of Clinical Oncology
- Vol. 18 (5) , E495-E506
Predictive factors associated with resistance to initial methotrexate treatment in women with low‐risk gestational trophoblastic neoplasia
Aim: To compare clinical characteristics and identify factors predictive of resistance to initial treatment with methotrexate‐folinic acid (MTX‐FA) in women with low‐risk gestational trophoblastic neoplasia (GTN).Methods: Retrospective chart reviews were conducted in patients diagnosed with low‐risk GTN who were treated with MTX‐FA at Siriraj Hospital between 2002 and 2018. Demographic data, disease characteristics, treatment response, toxicity, and data of the subsequent pregnancy were collected and analyzed. Groups of patients who were responsive or resistant to treatment were compared. Stepwise logistic regression analysis was used to identify factors predictive of resistance to methotrexate chemotherapy.Results: Totally, 113 patients were eligible for analysis. The primary remission rate was 55.8% with first‐line MTX‐FA. All other patients achieved remission by subsequent treatment with actinomycin D or multiple‐agent chemotherapy. Relapse of disease occurred in 4.4% and the overall survival rate was 99.1%. Univariate analysis showed that pretreatment serum hCG, neutrophil‐to‐lymphocyte ratio at baseline, and serum hCG ratio of the first three consecutive cycles (C) were significantly associated with resistance to MTX‐FA. Independent factors that predict failure to respond to first‐line MTX‐FA were pretreatment serum hCG ≥15,000 IU/L, a less than 4.8‐fold reduction of serum hCG between cycle 1 and cycle 2 (C1/C2), and a less than seven‐fold reduction of serum hCG from cycle 2 to cycle 3 (C2/C3).Conclusions: First‐line MTX‐FA treatment is effective in 55.8% of patients. Pretreatment serum hCG, and serum hCG ratio between consecutive treatment cycles can predict initial treatment failure.
- 9 January 2009
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 25 (S1) , 139-148
Myocardial perfusion cardiac magnetic resonance for the diagnosis of coronary artery disease: do we need rest images?
Adenosine stress cardiovascular magnetic resonance (CMR) has been reported to be useful for the diagnosis of coronary artery disease (CAD). Most studies use rest and stress perfusion images. The objectives of this study were to determine (Barkhausen et al. in J Magn Reson Imaging 19(6):750–757, 1) the accuracy of visual assessment and myocardial perfusion reserve index (MPRI) in the diagnosis of CAD and (Rieber et al. in Fur Heart J 27(12):1465–1471, 2) the accuracy of analysis based on rest–stress and stress images. We enrolled patients with suspected CAD and referred them for coronary angiography (CAG). All the patients underwent adenosine stress CMR before CAG. Rest and stress perfusion images were analyzed by calculation of MPRI and visual assessment separately. Visual assessment was performed separately by using rest and stress images and by using only stress images. CAG was considered the gold standard. Sensitivity, specificity, and accuracy of both methods were calculated and compared. A total of 66 patients (mean age, 61.3 ± 11.7 years) were studied. Thirty-eight patients (57.6%) were diagnosed with CAD. The sensitivity and specificity for the diagnosis of CAD (≥50% stenosis) were 89.5 and 78.6% for MPRI, 76.3 and 75% for stress–rest visual method, and 86.8 and 75% for stress visual method, respectively. CMR perfusion had a relatively lower accuracy in patients with left ventricular systolic dysfunction, high left ventricular mass, or presence of late gadolinium enhancement than in patients without those CMR findings. Visual assessment of stress image of CMR perfusion is accurate and comparable to MPRI for the detection of CAD.
- 9 January 2009
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 25 (S1) , 139-148
Myocardial perfusion cardiac magnetic resonance for the diagnosis of coronary artery disease: do we need rest images?
Adenosine stress cardiovascular magnetic resonance (CMR) has been reported to be useful for the diagnosis of coronary artery disease (CAD). Most studies use rest and stress perfusion images. The objectives of this study were to determine (Barkhausen et al. in J Magn Reson Imaging 19(6):750–757, 1) the accuracy of visual assessment and myocardial perfusion reserve index (MPRI) in the diagnosis of CAD and (Rieber et al. in Fur Heart J 27(12):1465–1471, 2) the accuracy of analysis based on rest–stress and stress images. We enrolled patients with suspected CAD and referred them for coronary angiography (CAG). All the patients underwent adenosine stress CMR before CAG. Rest and stress perfusion images were analyzed by calculation of MPRI and visual assessment separately. Visual assessment was performed separately by using rest and stress images and by using only stress images. CAG was considered the gold standard. Sensitivity, specificity, and accuracy of both methods were calculated and compared. A total of 66 patients (mean age, 61.3 ± 11.7 years) were studied. Thirty-eight patients (57.6%) were diagnosed with CAD. The sensitivity and specificity for the diagnosis of CAD (≥50% stenosis) were 89.5 and 78.6% for MPRI, 76.3 and 75% for stress–rest visual method, and 86.8 and 75% for stress visual method, respectively. CMR perfusion had a relatively lower accuracy in patients with left ventricular systolic dysfunction, high left ventricular mass, or presence of late gadolinium enhancement than in patients without those CMR findings. Visual assessment of stress image of CMR perfusion is accurate and comparable to MPRI for the detection of CAD.